EP3554958A1 - Spender von ophthalmischen lösungen für einzeldosisbehälter - Google Patents
Spender von ophthalmischen lösungen für einzeldosisbehälterInfo
- Publication number
- EP3554958A1 EP3554958A1 EP17826569.0A EP17826569A EP3554958A1 EP 3554958 A1 EP3554958 A1 EP 3554958A1 EP 17826569 A EP17826569 A EP 17826569A EP 3554958 A1 EP3554958 A1 EP 3554958A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dispenser
- opening
- fins
- dispenser according
- tip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D47/00—Closures with filling and discharging, or with discharging, devices
- B65D47/04—Closures with discharging devices other than pumps
- B65D47/06—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages
- B65D47/18—Closures with discharging devices other than pumps with pouring spouts or tubes; with discharge nozzles or passages for discharging drops; Droppers
Definitions
- the present invention relates to a dispenser of ophthalmic solutions applicable to single- dose containers.
- a sterile dispenser which is packaged individually and can be sold either individually or as a set, together with said single-dose containers.
- the single-dose containers preferably contain an ophthalmic solution, for example, a lissamine green-based solution.
- colouring agents are a group of substances used in the contact lens field for diagnostic purposes.
- vital staining with sodium fluorescein and/or lissamine green is usually used in the diagnosis of corneal and conjunctival anomalies. While fluorescein predominantly shows a loss of epithelial cells, lissamine green identifies devitalized or suffering cells.
- fluorescein and lissamine green are available in solutions contained in normal eye drop containers, or in the form of small paper strips soaked in the substance. More specifically, lissamine green is an organic acidic dye, which is produced synthetically; the staining properties thereof are very similar to those obtained when using rose bengal. However, unlike rose bengal, lissamine green is painless and offers a better colour contrast to vessels and bleeding. Lissamine green selectively stains suffering and dehydrated cells, guaranteeing observation of the conjunctival epithelium and highlighting abraded or desquamated epithelial areas.
- dyes are administered to the patient's eye with the aid of commonly known dispensers, for example of the type coupled directly (as a top) to commonly known eye drop containers.
- a large drop of dye is deposited on the cornea and much of the solution is lost through the tear duct or outside the eye.
- the dye is lissamine green, which is a very strong dye, if one administers too large a drop of eye drop to the eye there is a risk of temporarily staining the skin on the patient's face.
- the tip of the dispenser inadvertently touches the surface of the patient's cornea, thereby compromising the sterility of all the solution present in the container coupled directly to the dispenser.
- the object of the present invention is to provide a dispenser of ophthalmic solutions applicable to single-dose containers which overcomes the drawbacks of the prior art.
- a further object of the invention is to provide a dispensing device which allows the user to operate in total safety, preventing conveying contaminating agents to a patient.
- the dispenser reduces the waste of ophthalmic solution and prevents dispensing a greater amount of solution than that required into the patient's eye.
- the invention allows precise and rapid dispensing of the solution, in exactly the spot desired by the doctor.
- Figure 1 is a longitudinal lateral section view of the dispenser according to the present invention.
- Figure 1 A is an enlarged view of the detail circled in Figure 1;
- Figure 2 is a lateral view of the dispenser in Figure 1 when placed on a work surface
- Figure 3 is a longitudinal section of a dispenser when coupled to a single-dose container, also sectioned;
- Figure 4 shows a perspective view of the dispenser in Figure 1
- Figure 5 is a top view of the dispenser in Figure 1 ;
- Figure 6 is a lateral view of a different embodiment of the dispenser in Figure 1 ;
- Figure 7 is a longitudinal section of a different embodiment of the dispenser in Figure 1 ;
- Figure 8 is a view of a sterile bag within which the dispenser in Figure 1 may be marketed;
- reference number 1 is used to denote, as a whole, a dispenser of ophthalmic solutions.
- the dispenser 1 may be advantageously applied to single-dose containers of ophthalmic solutions, in particular those containing staining solutions, to be used during eye examinations.
- a solution for which the dispenser 1 is particularly effective comprises lissamine green.
- the single-dose container 2 may be a vial (possibly of the re-sealable type) made of polymeric material, of a soft, semi-transparent type, which contains an ophthalmic solution.
- Such vials 2 may comprise a body 2A for containing the solution, with an elongated, tubular conformation, which has an end having a neck 2B, at the top of which a product dispensing outlet 2C is formed.
- the opposite end of the vial to the neck 2B is sealed (e.g. by welding 2D which may be either of the hot or ultrasound variety) following insertion into the vial 2 of the ophthalmic solution 3.
- the vials may further comprise sealing means, which can be removably coupled to the vial at the neck, to allow closure of the dispensing outlet 2C.
- One type of these commonly known vials features the containment body and the sealing means made as a single piece, by means of injection moulding, and subsequently separated by the user, prior to use.
- the sealing means may be removed by detachment from the containment body 2A, thereby forming the said dispensing outlet 2C.
- One vial of this type features, at the dispensing outlet, an annular edge projecting inwardly and extending transversely to the containment body, said edge forming a central passage which allows the product to flow out.
- each vial features a different passage section from the others.
- the portion of vial bordering the dispensing outlet, following opening is jagged and may also feature plastic protrusions, which decrease the passage section for the solution 3.
- the dispensing outlet 2C of a conventional vial 2 has a passage section which allows the dispensing of individual drops with an average volume of about 0.04 ml, but obviously this volume changes depending on the substance to be administered.
- the present invention relates to a dispenser of ophthalmic solutions applicable to single - dose containers 2 similar to those disclosed above, i.e. which comprise a dispensing outlet 2C formed as a result of the mechanical breakage of the neck of the said container.
- the single-dose containers 2 preferred for the use of the dispenser are made of a soft plastic (for example low-density polythene) and as a single, injection-moulded piece.
- single-dose container should be understood as a container designed to hold ophthalmic solution in an amount ranging from 0.2 and 0.5 ml, but in this case the single dose will have a content of about 0.3 ml.
- the dispenser 1 comprises a body 4 which defines a cavity 5 connected to a first opening 6; the first opening 6 is coupled, by means of sealing means 7, configured to cooperate, during use, with the neck 2B of said single-dose container 2.
- the dispenser 1 furthermore comprises a dispensing tip 8 featuring a second opening 9, which is also connected to said cavity 5; the second opening 9 may be configured to dispense drops of a volume between 0.005 ml and 0.02 ml, preferably between 0.01 and 0.015 ml.
- the second opening 9 (which can be seen in Figure 1A) may be a hole with a diameter D2 of between 0.25 and 0.75 mm, preferably between 0.4 and 0.6 mm, again more preferably of 0.5 mm.
- the second opening 9 may be defined by means of a first conical surface 10, which is inclined by 1° to 10°, more preferably by 2° to 4°, but still more preferably by 3°, with respect to a longitudinal axis A of said dispenser.
- the first surface 10 may extend along the entire length B l of the dispensing tip.
- the first conical surface 10 may extend along an axial length of between 8 and 20 mm.
- the first surface 10 may be followed (in the dispensing direction, Arrow E) by a second conical surface 11 inclined by 2° to 45°, more preferably by 8° to 12°, but still more preferably by 10°, with respect to said axis A.
- the height HA of the second conical surface may be between 0.1 and 0.6 mm.
- the first opening 6 may be coupled to sealing means, which may comprise, for example, at least one sealing ring 7, formed as a part of the dispenser body.
- the sealing means 7 may be simply formed of a conical coupling wall suitable to couple, in a sealed fashion, with the neck of said single-dose container.
- the material of which the single-dose container 2 is usually made is rather soft and elastic, as the user must be able to apply pressure to the outside of the container in order to dispense the ophthalmic solution. This material is therefore suitable to provide a good seal at the opening 6, even in the absence of sealing rings 7.
- the said body features a plurality of gripping fins 13 A, 13B, 13C ... (denoted, overall, as 13) which facilitate the handling of the dispenser 1.
- the optimal number of fins is six, which should be spaced at 60 degree angles. However, it is also possible for a different number of fins to be present, for example from three to twelve.
- a barycentre B of the dispenser may be positioned in a portion of the body 2 where the fins 13 are present.
- the fins 13 have an external surface 14 which defines a support surface for the dispenser 1 (see Figure 2).
- the outer surface 14 of each fin may be inclined with respect to the axis A so that when the said surface is resting on a surface P (for example a table), said dispensing tip is raised off said surface P, so as to prevent contamination.
- the inclination a of the external surface 14 of the fins and the length Bl, B2 of the tip are linked so as to prevent the tip (and in particular the second opening 9) coming into contact with the surface P when the surface 14 of the fins is resting on the surface P.
- Figure 6 shows a variant of the dispenser in Figure 1.
- the tip in Figure 1 has a length B l of 10 mm, while the tip in Figure 2 has a length B2 of 15 mm.
- the tip length takes on particular importance as a longer tip 8 provides greater precision when positioning the dispensing outlet within a desired area of the cornea.
- a tip with the length described allows the doctor to administer a drop with minimal risk of contact with the patient's eye.
- the fins 13 extend longitudinally beyond said first opening 6, in the opposite direction to the tip 8.
- the dispenser 1 may also be placed on the surface P by making use of the base B of the fins 13.
- the opening 6 remains spaced well apart from the support surface 6, and therefore the sterility of the dispenser is maintained.
- the entire dispenser 1, and more specifically, the body 2, the tip 8, and the wings 13 are made, by injection moulding, as a single piece of sterilizable plastic.
- Suitable plastics for manufacturing the dispenser preferably belong to the polyolefin family (PP, LDPE), but for some applications, other plastic materials such as PET may also be used.
- One plastic material which is particularly suitable for manufacturing the dispenser 1 is that used for the single-dose container 2.
- the dispenser 1 in a set, which comprises, in addition to the said dispenser (individually packaged in a sterile or sterilizable package 20), at least one single-dose container 2 of ophthalmic solution configured to cooperate with said dispenser.
- a doctor or any personnel authorised to examine a patient, may prepare a single-dose container 2, by - for example - separating said container from the others connected thereto via the breakable portions 25A featured on the lugs 25 protruding laterally from the single-dose container 2 or vial.
- the doctor can open the single-dose container by detaching a seal (not shown) from the vial 2.
- the doctor subsequently (or even prior to the operations described), can open the sterile package 20 and prepare a dispenser 1. If the situation requires it, the doctor can place the dispenser on a flat surface P, maintaining the sterility thereof by virtue of the fins 13 (or bases B thereof).
- the doctor can fit the dispenser 1 onto the neck of the single-dose container 2, thereby obtaining the configuration shown in Figure 3.
- the single-dose container 2/dispenser 1 assembly is ready for use and the doctor can easily administer to the patient's eye, in a precise area of the cornea, a drop of the solution contained in the single-dose container 2. This can be done by exerting slight pressure to the deformable body 2A of the single-dose container.
- the dispensing 1 it is possible to administer, to the patient's eye, the exact amount of ophthalmic solution necessary for the examination to be carried out.
- the dispenser makes it possible to administer, in a very precise way, solely the amount necessary to carry out the examination, thereby preventing the solution overflowing from the patient's eye and staining the skin of the face thereof.
- the use of a thin and flexible tip minimises the risk of injury in the event that the tip inadvertently comes into contact with the eye.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000126907A IT201600126907A1 (it) | 2016-12-15 | 2016-12-15 | Dosatore di soluzioni oftalmiche applicabile a contenitori monodose |
| PCT/IB2017/057948 WO2018109712A1 (en) | 2016-12-15 | 2017-12-14 | Dispenser of ophthalmic solutions applicable to single-dose containers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP3554958A1 true EP3554958A1 (de) | 2019-10-23 |
| EP3554958B1 EP3554958B1 (de) | 2023-07-05 |
| EP3554958C0 EP3554958C0 (de) | 2023-07-05 |
Family
ID=58455549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17826569.0A Active EP3554958B1 (de) | 2016-12-15 | 2017-12-14 | Spender von ophthalmischen lösungen für einzeldosisbehälter |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3554958B1 (de) |
| IT (1) | IT201600126907A1 (de) |
| WO (1) | WO2018109712A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060081726A1 (en) * | 2004-10-14 | 2006-04-20 | Gerondale Scott J | Controlled drop dispensing tips for bottles |
| AU2007330356B2 (en) * | 2006-12-07 | 2013-05-02 | Sun Pharma Advanced Research Company Ltd | Metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop |
| IT1393560B1 (it) * | 2009-01-21 | 2012-04-27 | Lameplast Spa | Contenitore per prodotti fluidi, particolarmente prodotti farmaceutici, cosmetici, medicali o simili |
-
2016
- 2016-12-15 IT IT102016000126907A patent/IT201600126907A1/it unknown
-
2017
- 2017-12-14 EP EP17826569.0A patent/EP3554958B1/de active Active
- 2017-12-14 WO PCT/IB2017/057948 patent/WO2018109712A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IT201600126907A1 (it) | 2018-06-15 |
| WO2018109712A1 (en) | 2018-06-21 |
| EP3554958B1 (de) | 2023-07-05 |
| EP3554958C0 (de) | 2023-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW317504B (de) | ||
| ES2336536T3 (es) | Distribuidor de medicamentos. | |
| US7527613B2 (en) | Therapeutic solution drop dispenser | |
| US5221027A (en) | Fluid dispenser tip with recessed dispensing nozzle | |
| AU619989B1 (en) | Liquid droplet dispensing apparatus | |
| US20140350492A1 (en) | Eyedrop dispenser | |
| JPH04272757A (ja) | スリーブ付き投与びん | |
| JP2003512107A (ja) | 医薬品のパッケージ及びパッケージを製造し、滅菌する方法 | |
| KR102728861B1 (ko) | 주사기 몸체 | |
| KR20240101806A (ko) | 경구 백신 투여를 위한 앰플 및 사용 방법 | |
| US3938518A (en) | Syringe attachment device | |
| BE1000455A7 (nl) | Naaldsamenstel voor het overbrengen van vloeistoffen. | |
| KR102171701B1 (ko) | 약물 혼합용 키트 및 이를 포함하는 밀봉팩 | |
| EP3554958B1 (de) | Spender von ophthalmischen lösungen für einzeldosisbehälter | |
| US20070179457A1 (en) | Device and method for the administration of eye drops | |
| US4125186A (en) | Pharmaceutical delivery system | |
| TW202525367A (zh) | 用於包裝預填充注射器的容器 | |
| US20060282049A1 (en) | Eye fluid dispensing apparatus | |
| US20190117917A1 (en) | Two-part plastic blank set | |
| IT201600126875A1 (it) | Dosatore di soluzioni oftalmiche applicabile a contenitori monodose | |
| CN116529169A (zh) | 具有分配口保护装置的可再封闭容器 | |
| US2861572A (en) | Medicament dispenser | |
| CN209500275U (zh) | 一种折断式眼药包材 | |
| JP4324287B2 (ja) | トランスファーニードル | |
| RU168297U1 (ru) | Флакон-капельница для жидких лекарственных форм |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20190614 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20230130 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1584660 Country of ref document: AT Kind code of ref document: T Effective date: 20230715 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017071022 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| U01 | Request for unitary effect filed |
Effective date: 20230724 |
|
| U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20230727 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231006 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231105 |
|
| U20 | Renewal fee for the european patent with unitary effect paid |
Year of fee payment: 7 Effective date: 20231220 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231005 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231105 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231006 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017071022 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20240408 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20231214 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231214 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231214 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231231 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231214 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231214 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231231 |
|
| U20 | Renewal fee for the european patent with unitary effect paid |
Year of fee payment: 8 Effective date: 20241113 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20171214 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20171214 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230705 |
|
| U20 | Renewal fee for the european patent with unitary effect paid |
Year of fee payment: 9 Effective date: 20251112 |